AtriCure (ATRC) Share-based Compensation (2010 - 2026)

AtriCure (ATRC) has 17 years of Share-based Compensation data on file, last reported at $11.4 million in Q1 2026.

• On a quarterly basis, Share-based Compensation rose 12.49% year-over-year to $11.4 million in Q1 2026; TTM through Mar 2026 was $12.4 million, a 58.22% increase from a year earlier, with the FY2025 full-year figure at $11.2 million, up 60.6% from the prior year.
• Share-based Compensation for Q1 2026 stood at $11.4 million, up from $228000.0 in the prior quarter.
• Over the last five years, Share-based Compensation for ATRC reached as high as $16.6 million in Q4 2022 and fell as low as -$12.9 million in Q3 2024.
• Historically, Share-based Compensation has averaged $5.5 million across 5 years, with a median of $8.8 million in 2023.
• Across the five-year window, Share-based Compensation jumped 758.03% in 2022 and tumbled 248.91% in 2024, its largest moves.
• Year by year, Share-based Compensation stood at $16.6 million in 2022, then sank by 44.02% to $9.3 million in 2023, then slumped by 97.94% to $192000.0 in 2024, then increased by 18.75% to $228000.0 in 2025, then jumped by 4918.42% to $11.4 million in 2026.
• Per Business Quant data, the three most recent Share-based Compensation figures were $11.4 million in Q1 2026, $228000.0 in Q4 2025, and $357000.0 in Q3 2025.